See more : Universal Music Group N.V. (UMGNF) Income Statement Analysis – Financial Results
Complete financial analysis of Kolon Corporation (002020.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kolon Corporation, a leading company in the Conglomerates industry within the Industrials sector.
- Bentley Capital Limited (BEL.AX) Income Statement Analysis – Financial Results
- Phio Pharmaceuticals Corp. (PHIOW) Income Statement Analysis – Financial Results
- Storage Computer Corporation (SOSO) Income Statement Analysis – Financial Results
- SmartKem, Inc. (SMTK) Income Statement Analysis – Financial Results
- Lendlease Group (LLESF) Income Statement Analysis – Financial Results
Kolon Corporation (002020.KS)
About Kolon Corporation
Kolon Corporation engages in supporting and managing affiliate businesses, licensing intellectual property, and market research and management consulting businesses in South Korea and internationally. The company manufactures tire cords, airbags, polyester spunbond, technical yarns, aramid products, membranes, polyester and nylon films, coated films, DFR materials, overcoats, beads, hydrocarbon and phenolic resins, epoxy resins, PU/TPU products, and glass reinforced plastic pipes. It also offers nylon and polyester fibers; woven, knit, and functional fabrics; trades in steel, natural resources, and chemicals; and provides residential and plant construction services, as well as undertakes civil engineering and environmental projects. In addition, the company produces car seat modules and fabrics, car mats, artificial turfs, polypropylene staple fibers, Bicomponent staple fiber, GEONIC, Cuprus, and HeaTex, and polyester filaments; manages hotels, condominiums, and golf resorts; develops real estate properties; and operates a shopping mall, a pet theme park, and themed toilets. Further, it offers over-the-counter medicines; TRAMOL sustained relief, a painkiller and anti-inflammatory; active pharmaceutical ingredients; and Tissuegene and other biopharmaceuticals, as well as operates approximately 150 drugstores under the W-Store name. Additionally, the company operates Sweet Meal, a café that offers choux, coffee, cheesecakes, and beverages; sells antimicrobial products; provides PA, PBT, and POM/base and compound resins; retails hardware and software products; and offers IT and business process outsourcing and IT convergence services. It also engages in water-related businesses covering sewage and wastewater treatment, materials, systems, and related equipment, as well as operates water treatment facilities; and industrial supply retail. Kolon Corporation was founded in 1957 and is headquartered in Gwacheon, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,894.23B | 5,659.92B | 5,410.41B | 4,890.15B | 4,405.96B | 4,324.49B | 4,352.97B | 3,884.32B | 3,816.28B | 4,103.09B | 4,390.32B | 4,664.99B | 502.68B | 215.52B | 3,282.19B | 4,886.49B | 3,304.01B |
| Cost of Revenue | 5,399.63B | 4,974.43B | 4,747.52B | 4,292.57B | 3,939.54B | 3,877.50B | 3,916.46B | 3,478.12B | 3,410.20B | 3,684.27B | 3,937.69B | 4,243.83B | 415.33B | 147.41B | 2,671.51B | 3,917.22B | 2,924.70B |
| Gross Profit | 494.60B | 685.49B | 662.90B | 597.58B | 466.42B | 446.99B | 436.51B | 406.20B | 406.08B | 418.82B | 452.62B | 421.16B | 87.34B | 68.11B | 610.68B | 969.26B | 379.30B |
| Gross Profit Ratio | 8.39% | 12.11% | 12.25% | 12.22% | 10.59% | 10.34% | 10.03% | 10.46% | 10.64% | 10.21% | 10.31% | 9.03% | 17.38% | 31.60% | 18.61% | 19.84% | 11.48% |
| Research & Development | 4.24B | 2.54B | 1.58B | 2.69B | 5.31B | 6.30B | 4.89B | 4.39B | 5.91B | 5.74B | 7.14B | 6.26B | 2.52B | 2.19B | 23.64B | 27.58B | 22.81B |
| General & Administrative | 45.63B | 42.38B | 38.49B | 35.98B | 40.24B | 43.34B | 46.04B | 40.57B | 41.67B | 43.28B | 50.59B | 41.34B | 8.55B | 8.94B | 27.49B | 41.21B | 23.60B |
| Selling & Marketing | 80.57B | 66.91B | 43.67B | 49.51B | 43.55B | 46.92B | 65.77B | 57.24B | 70.32B | 79.09B | 87.50B | 86.64B | 16.97B | 58.20B | 232.42B | 419.09B | 120.32B |
| SG&A | 324.07B | 109.29B | 82.16B | 85.49B | 83.79B | 90.26B | 111.81B | 97.81B | 111.99B | 122.37B | 138.09B | 127.97B | 25.52B | 67.15B | 259.91B | 460.30B | 143.92B |
| Other Expenses | 0.00 | 258.46B | 243.82B | 236.24B | 248.67B | 237.01B | 28.78B | -12.41B | -3.87B | -41.32B | -17.34B | 11.09B | -28.15B | -21.21B | 2.38B | -5.46B | -42.13B |
| Operating Expenses | 321.27B | 370.28B | 327.55B | 324.42B | 337.77B | 333.57B | 343.78B | 315.03B | 313.01B | 355.65B | 400.28B | 395.34B | -108.10M | 67.54B | 406.47B | 762.12B | 295.20B |
| Cost & Expenses | 5,720.90B | 5,344.71B | 5,075.07B | 4,616.99B | 4,277.31B | 4,211.07B | 4,260.24B | 3,793.16B | 3,723.21B | 4,039.92B | 4,337.98B | 4,639.17B | 415.23B | 214.95B | 3,077.98B | 4,679.34B | 3,219.90B |
| Interest Income | 27.76B | 25.12B | 9.79B | 6.61B | 11.19B | 12.16B | 8.47B | 5.86B | 4.10B | 8.89B | 14.48B | 17.55B | 2.19B | 2.46B | 5.93B | 9.36B | 5.30B |
| Interest Expense | 120.92B | 68.98B | 48.41B | 61.51B | 80.37B | 65.61B | 59.90B | 54.32B | 66.11B | 91.14B | 104.80B | 103.68B | 18.88B | 11.86B | 82.98B | 109.44B | 82.08B |
| Depreciation & Amortization | 83.54B | 73.41B | 81.46B | 84.47B | 84.58B | 34.52B | 30.00B | 26.98B | 31.46B | 30.73B | 33.03B | 26.13B | 10.42B | 8.84B | 180.43B | 183.24B | 142.74B |
| EBITDA | 221.14B | 370.64B | 313.38B | 255.67B | 197.16B | 113.32B | 203.71B | 72.77B | 75.97B | 120.35B | 102.70B | 89.86B | 99.98B | 104.07B | 382.20B | 384.75B | 226.51B |
| EBITDA Ratio | 3.75% | 7.63% | 6.79% | 7.47% | 4.31% | 3.26% | 4.89% | 2.35% | 2.01% | 3.28% | 2.19% | 1.93% | 19.89% | 29.01% | 11.98% | 7.31% | 7.04% |
| Operating Income | 173.33B | 310.97B | 332.20B | 271.45B | 124.52B | 111.46B | 106.76B | 136.87B | 41.36B | 72.66B | 76.92B | 43.37B | 115.43B | 92.74B | 204.21B | 207.14B | 84.10B |
| Operating Income Ratio | 2.94% | 5.49% | 6.14% | 5.55% | 2.83% | 2.58% | 2.45% | 3.52% | 1.08% | 1.77% | 1.75% | 0.93% | 22.96% | 43.03% | 6.22% | 4.24% | 2.55% |
| Total Other Income/Expenses | -148.71B | -72.21B | -90.08B | -89.07B | -129.89B | -93.17B | 4.82B | -44.19B | -78.55B | -69.27B | -107.16B | -64.07B | -16.66B | -9.37B | -85.43B | -115.08B | -82.41B |
| Income Before Tax | 24.62B | 256.63B | 242.12B | 182.38B | -7.60B | 18.29B | 124.89B | 40.98B | -24.24B | 1.55B | -30.24B | -13.93B | 98.77B | 83.37B | 118.78B | 92.06B | 1.69B |
| Income Before Tax Ratio | 0.42% | 4.53% | 4.48% | 3.73% | -0.17% | 0.42% | 2.87% | 1.06% | -0.64% | 0.04% | -0.69% | -0.30% | 19.65% | 38.68% | 3.62% | 1.88% | 0.05% |
| Income Tax Expense | 9.23B | 89.74B | 85.32B | 55.08B | 14.62B | 16.65B | 15.30B | 9.91B | 12.23B | -19.00B | 54.62B | -8.68B | 9.99B | 11.14B | 8.57B | 26.29B | 3.11B |
| Net Income | 8.57B | 159.88B | 128.38B | 149.25B | -22.22B | 1.47B | 97.22B | 20.46B | -64.02B | 10.18B | -44.47B | 2.14B | 84.95B | 67.32B | 107.88B | 79.33B | 19.29B |
| Net Income Ratio | 0.15% | 2.82% | 2.37% | 3.05% | -0.50% | 0.03% | 2.23% | 0.53% | -1.68% | 0.25% | -1.01% | 0.05% | 16.90% | 31.24% | 3.29% | 1.62% | 0.58% |
| EPS | 625.15 | 11.67K | 9.37K | 8.88K | -1.62K | 112.21 | 6.56K | 1.55K | -4.88K | 771.00 | -3.74K | 232.00 | 7.14K | 8.51K | 6.31K | 17.77K | 4.52K |
| EPS Diluted | 621.30 | 11.50K | 9.21K | 8.84K | -1.62K | 108.76 | 6.39K | 1.51K | -4.88K | 762.00 | -3.74K | 230.00 | 7.13K | 8.34K | 5.63K | 17.68K | 4.52K |
| Weighted Avg Shares Out | 13.70M | 13.70M | 13.70M | 13.70M | 13.70M | 13.10M | 13.15M | 13.18M | 13.13M | 13.20M | 11.90M | 14.64M | 11.82M | 7.91M | 4.66M | 4.46M | 4.27M |
| Weighted Avg Shares Out (Dil) | 13.79M | 13.90M | 13.94M | 13.77M | 13.70M | 13.52M | 13.49M | 13.58M | 13.13M | 13.36M | 11.90M | 14.76M | 11.83M | 8.07M | 5.24M | 4.49M | 4.27M |
Source: https://incomestatements.info
Category: Stock Reports